Received Aug 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y017527 | — |
HBP calling on behalf of the HCP to report an AE with the MMR II vaccine. HBP reported that a patient was inadvertently administered a dose of the MMR II vaccine that was reconstituted with the MENQUADFI vaccine. HBP did not report any side effects o; HBP calling on behalf of the HCP to report an AE with the MMR II vaccine. HBP reported that a patient was inadvertently administered a dose of the MMR II vaccine that was reconstituted with the MENQUADFI vaccine. HBP did not report any side effects o; HBP calling on behalf of the HCP to report an AE with the MMR II vaccine. HBP reported that a patient was inadvertently administered a dose of the MMR II vaccine that was reconstituted with the MENQUADFI vaccine. HBP did not report any side effects o; This spontaneous report was received from a consumer or other non-health professional and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 05-AUG-2025, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (valid lot number Y017527, expiration date: 21-OCT-2026) for prophylaxis. The patient was inadvertently administered a dose of the Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) vaccine that was reconstituted with the Meningococcal vaccine A/C/Y/W conj (tet tox)) (MENQUADFI) vaccine (lot number and expiration date were not reported) for prophylaxis. The reporter did not report any side effects or adverse events associated with the administration (accidental exposure to product, vaccine coadministration, product preparation error). At the reporting time, the outcome of the event vaccine coadministration was not provided. The causal relationship between the event vaccine coadministration the suspect vaccines was not reported.